Ottawa Heart Institute Research Corporation [clinicaltrials_resource:03bfe99711b9a3112bcdfb93f79d6f19]
Robert Reid, MBA, PhD [clinicaltrials_resource:01492f08c3a51a5822f92c4880cf1bd7]Robert D Reid, MBA, PhD [clinicaltrials_resource:015a277e90e9ec545195eb50afdd4b9a]Robert Reid, Dr. [clinicaltrials_resource:02f15413eace10cc09df6be0ba379a0f]Girish Nair, MD [clinicaltrials_resource:03ae049c66c2a3d7f2c256e7d98d399c]Benjamin Hibbert, MD, PhD [clinicaltrials_resource:04b1cd5b77128bb8910c1b7055fd55e4]Benjamin Hibbert, MD, PhD [clinicaltrials_resource:04c8824842d64e8253a3a73612279ff6]Antonio Pellicer, MDPhD [clinicaltrials_resource:04d4442faff5f7e35e194ccdd801cc11]Benjamin JW Chow, MD, FRCPC [clinicaltrials_resource:05398ec0b7f4342400c0dac41cf448dc]Atul Verma, MD [clinicaltrials_resource:054b315709ae3101bcd4bfb9a48cef37]Girish Nair, MD [clinicaltrials_resource:064c14579cfc7b75ee8fb096636023ac]Robert Lemery, MD [clinicaltrials_resource:06983fb14a70577a9278a51a379c7d11]David Birnie, MD [clinicaltrials_resource:07e0588905086440418c7a2515ffa2cf]Rob S Beanlands, MD, FRCP C [clinicaltrials_resource:08a222a01ab01cae6150eaab752cf121]Marc A Ruel, MD [clinicaltrials_resource:0ba803e87571f578ef8b4cd25edf878a]Pablo B Nery, MD [clinicaltrials_resource:0bf24a44aafda52d20e221dec59bfe2d]Pablo Nery, MD [clinicaltrials_resource:0c11a37703c742d366967afadb8d8cb3]Rob S Beanlands, MD [clinicaltrials_resource:10c17d32a15783e1f5d95b5d44a60103]Pablo B Nery, MD [clinicaltrials_resource:12b6e0245f3d58784404b849e345febd]Robert Reid, PhD., MBA [clinicaltrials_resource:14af9be992005f6f7eec48adf29f4e72]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Anthony Tang, MD [clinicaltrials_resource:16ab501402de4a62c4d89b6cdef5e372]Rob S. Beanlands, MD, FRCP C [clinicaltrials_resource:1cde4dc029008f0da9ea09349fb21a09]Michel R Le May, MD [clinicaltrials_resource:1ff0fec95eb76a691e1b4b0879b0d7b1]Rob S Beanlands, MD [clinicaltrials_resource:21a89abe0c0f09759d6a06404d196ef3]Pablo Nery, MD [clinicaltrials_resource:23a2efa053fc787211a0cfd601ebaebe]Robert Reid, PhD., MBA [clinicaltrials_resource:2444134909dad0f40369bf18de8a9af9]Robert Lemery, MD [clinicaltrials_resource:244e48798387394bade2ecf82292c662]Anthony SL Tang, MD [clinicaltrials_resource:266b72c6169d4799822eba1042a3ead1]Anthony SL Tang, MD [clinicaltrials_resource:29270e72f748044bfc40d2616477c1ce]Robert Reid, MBA, PhD [clinicaltrials_resource:2b94fb97c12985ccfc673ae3f8de37ff]Michel R Le May, MD [clinicaltrials_resource:307a9e31a857d884804025e8f90512f2]Marc Ruel, MD MPH FRCSC [clinicaltrials_resource:32167ed9ee60d1db2594934cbe1cc1b3]Rob S Beanlands, MD [clinicaltrials_resource:34f15494c73f2bff39d2ede23d17f648]Rob S Beanlands, MD [clinicaltrials_resource:363f3c11c37a220bb90c068b97f25086]Robert Reid, Dr. [clinicaltrials_resource:36f1b61f310fd0a082d361cc03262bce]Robert Lemery, MD [clinicaltrials_resource:37ec9cc9ef6bdf7a8dcc330ed70ddd3b]Girish Dwivedi, MD MRCP PhD [clinicaltrials_resource:3b12b20ccfdf972f14e38a69fec81de2]Robert Reid, PhD., MBA [clinicaltrials_resource:3b83fcd18e57594ea3c8827954eb2527]Robert Reid, MBA, PhD [clinicaltrials_resource:3c93e396c3f187d48616033076a4ec6b]Robert Reid, PhD, MBA [clinicaltrials_resource:3fd0a36461554845ce6cc406aa466433]
affiliation [clinicaltrials_vocabulary:affiliation]
Endothelial Modulation for Angiogenic Therapy [clinicaltrials:NCT00134433]clinicaltrials:NCT00228423A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Surgery [clinicaltrials:NCT00246779]Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy [clinicaltrials:NCT00247975]A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease [clinicaltrials:NCT00248352]The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI) [clinicaltrials:NCT00250913]Resynchronization/Defibrillation for Ambulatory Heart Failure Trial [clinicaltrials:NCT00251251]Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI) [clinicaltrials:NCT00251823]Evaluation of a Web-based Intervention to Promote Physical Activity in Patients With Heart Disease. [clinicaltrials:NCT00265525]PET and Recovery Following Revascularization (PARR 2) [clinicaltrials:NCT00385242]Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease [clinicaltrials:NCT00449852]clinicaltrials:NCT00465218Family Heart Health Program: Randomized, Controlled Trial [clinicaltrials:NCT00552591]Discerning Symptomatic and Asymptomatic Episodes Pre and Post Radiofrequency Ablation of Atrial Fibrillation [clinicaltrials:NCT00745706]clinicaltrials:NCT00756366Cardiac FDG PET Viability Registry [clinicaltrials:NCT00766987]clinicaltrials:NCT00800137clinicaltrials:NCT00959972Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease [clinicaltrials:NCT00962988]clinicaltrials:NCT01128023Using Automated Calls To Improve Compliance With Acute Coronary Syndrome Best Practice Guidelines [clinicaltrials:NCT01151800]clinicaltrials:NCT01184300Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease [clinicaltrials:NCT01236508]clinicaltrials:NCT01281384clinicaltrials:NCT01283659clinicaltrials:NCT01288560Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation [clinicaltrials:NCT01420393]clinicaltrials:NCT01452139Cardiac Sarcoidosis Multi-Center Prospective Cohort [clinicaltrials:NCT01477359]A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy Volunteers [clinicaltrials:NCT01558362]Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension [clinicaltrials:NCT01572077]Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation [clinicaltrials:NCT01622998]clinicaltrials:NCT01623505clinicaltrials:NCT01658683clinicaltrials:NCT01675076clinicaltrials:NCT01994252clinicaltrials:NCT02043522A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk [clinicaltrials:NCT02044146]Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH [clinicaltrials:NCT02094001]clinicaltrials:NCT02117284
collaborator [clinicaltrials_vocabulary:collaborator]
Endothelial Modulation for Angiogenic Therapy [clinicaltrials:NCT00134433]clinicaltrials:NCT00228423A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Surgery [clinicaltrials:NCT00246779]Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy [clinicaltrials:NCT00247975]A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease [clinicaltrials:NCT00248352]The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI) [clinicaltrials:NCT00250913]Resynchronization/Defibrillation for Ambulatory Heart Failure Trial [clinicaltrials:NCT00251251]Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI) [clinicaltrials:NCT00251823]Evaluation of a Web-based Intervention to Promote Physical Activity in Patients With Heart Disease. [clinicaltrials:NCT00265525]PET and Recovery Following Revascularization (PARR 2) [clinicaltrials:NCT00385242]Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT) [clinicaltrials:NCT00449826]Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease [clinicaltrials:NCT00449852]Comparison of Cardiac Computed Tomographic Angiography (CTA) to Tc-99m Single Photon Emission Computed Tomography (SPECT) [clinicaltrials:NCT00449943]clinicaltrials:NCT00465218Family Heart Health Program: Randomized, Controlled Trial [clinicaltrials:NCT00552591]Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis [clinicaltrials:NCT00612521]Discerning Symptomatic and Asymptomatic Episodes Pre and Post Radiofrequency Ablation of Atrial Fibrillation [clinicaltrials:NCT00745706]clinicaltrials:NCT00756366Cardiac FDG PET Viability Registry [clinicaltrials:NCT00766987]clinicaltrials:NCT00800137Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty [clinicaltrials:NCT00827346]clinicaltrials:NCT00959972Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease [clinicaltrials:NCT00962988]clinicaltrials:NCT01128023Using Automated Calls To Improve Compliance With Acute Coronary Syndrome Best Practice Guidelines [clinicaltrials:NCT01151800]clinicaltrials:NCT01184300clinicaltrials:NCT01210677Study to Monitor the Effects of Androgen Suppression Treatment on the Heart [clinicaltrials:NCT01230905]Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis [clinicaltrials:NCT01230918]Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease [clinicaltrials:NCT01236508]clinicaltrials:NCT01281384clinicaltrials:NCT01283659clinicaltrials:NCT01288560Femoral Versus Radial Access for Primary PCI [clinicaltrials:NCT01398254]Cost Free Pharmacotherapy for Smoking Cessation in Stroke Patients [clinicaltrials:NCT01404546]Accuracy of Half of the Usual Radiotracer Dose in SPECT [clinicaltrials:NCT01412827]Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation [clinicaltrials:NCT01420393]clinicaltrials:NCT01452139Cardiac Sarcoidosis Multi-Center Prospective Cohort [clinicaltrials:NCT01477359]Optimization of SPECT Imaging [clinicaltrials:NCT01519973]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Endothelial Modulation for Angiogenic Therapy [clinicaltrials:NCT00134433]clinicaltrials:NCT00228423A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Surgery [clinicaltrials:NCT00246779]Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy [clinicaltrials:NCT00247975]A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease [clinicaltrials:NCT00248352]The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI) [clinicaltrials:NCT00250913]Resynchronization/Defibrillation for Ambulatory Heart Failure Trial [clinicaltrials:NCT00251251]Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI) [clinicaltrials:NCT00251823]Evaluation of a Web-based Intervention to Promote Physical Activity in Patients With Heart Disease. [clinicaltrials:NCT00265525]PET and Recovery Following Revascularization (PARR 2) [clinicaltrials:NCT00385242]Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT) [clinicaltrials:NCT00449826]Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease [clinicaltrials:NCT00449852]Comparison of Cardiac Computed Tomographic Angiography (CTA) to Tc-99m Single Photon Emission Computed Tomography (SPECT) [clinicaltrials:NCT00449943]clinicaltrials:NCT00465218Family Heart Health Program: Randomized, Controlled Trial [clinicaltrials:NCT00552591]Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis [clinicaltrials:NCT00612521]Discerning Symptomatic and Asymptomatic Episodes Pre and Post Radiofrequency Ablation of Atrial Fibrillation [clinicaltrials:NCT00745706]clinicaltrials:NCT00756366Cardiac FDG PET Viability Registry [clinicaltrials:NCT00766987]clinicaltrials:NCT00800137Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty [clinicaltrials:NCT00827346]clinicaltrials:NCT00959972Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease [clinicaltrials:NCT00962988]clinicaltrials:NCT01128023Using Automated Calls To Improve Compliance With Acute Coronary Syndrome Best Practice Guidelines [clinicaltrials:NCT01151800]clinicaltrials:NCT01184300clinicaltrials:NCT01210677Study to Monitor the Effects of Androgen Suppression Treatment on the Heart [clinicaltrials:NCT01230905]Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis [clinicaltrials:NCT01230918]Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease [clinicaltrials:NCT01236508]clinicaltrials:NCT01281384clinicaltrials:NCT01283659clinicaltrials:NCT01288560Femoral Versus Radial Access for Primary PCI [clinicaltrials:NCT01398254]Cost Free Pharmacotherapy for Smoking Cessation in Stroke Patients [clinicaltrials:NCT01404546]Accuracy of Half of the Usual Radiotracer Dose in SPECT [clinicaltrials:NCT01412827]Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation [clinicaltrials:NCT01420393]clinicaltrials:NCT01452139Cardiac Sarcoidosis Multi-Center Prospective Cohort [clinicaltrials:NCT01477359]Optimization of SPECT Imaging [clinicaltrials:NCT01519973]
source [clinicaltrials_vocabulary:source]
Ottawa Heart Institute Research Corporation [clinicaltrials_resource:03bfe99711b9a3112bcdfb93f79d6f19]
Bio2RDF identifier
03bfe99711b9a3112bcdfb93f79d6f19
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:03bfe99711b9a3112bcdfb93f79d6f19
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:03bfe99711b9a3112bcdfb93f79d6f19
title
Ottawa Heart Institute Research Corporation
@en
type
label
Ottawa Heart Institute Researc ...... fe99711b9a3112bcdfb93f79d6f19]
@en